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Pulmonary tuberculosisAbstract Cancer antigen 125 (CA-125) is usually elevated in ovarian cancer. However, there are
several reports that serum CA-125 is elevated in tuberculosis.
Aim of the work: This study was done to evaluate the diagnostic value of serum level of CA-125
in active pulmonary tuberculosis and its relation to disease severity.
Subjects and methods: The study enrolled 80 patients who were selected from Damietta Chest
Hospital and Chest Department, Benha University Hospitals in the period from July 2013 to July
2014. The subjects were classiﬁed into 3 groups: group I: included 40 patients with new diagnosed
active pulmonary tuberculosis, group II: included 20 patients with pneumonia, group III: included
20 apparently healthy subjects as control group. The patients were subjected to full history taking,
full clinical examination, plain chest X-ray PA view, sputum examination for AFB for three succes-
sive days by direct smear for group I & II, tuberculin skin test, CBC and ESR and serum level of
CA-125 by ELIZA.
Results: There was a statistically signiﬁcant difference among the three studied groups according
to the serum level of CA 125 as it was signiﬁcantly higher in group I. The study revealed that serum
CA 125 levels in group I was signiﬁcantly higher in far advanced and moderate advanced disease
than minimal lesion one. There was a statistically signiﬁcant difference in serum CA 125 levels in
group I regarding the results of sputum analysis for AFB. Serum level of CA125 at a cut off value
of 21.05 U/ml has sensitivity, speciﬁcity, PPV, NPV, accuracy of 82.5%, 72.5%, 77.3%, 83.3% and
80.0% respectively in diagnosis of active pulmonary tuberculosis.
Conclusion: Serum CA-125 may be used as a marker for diagnosis and assessment of severity of
active pulmonary tuberculosis.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of The Egyptian Society of Chest
Diseases and Tuberculosis. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).rculosis.
Table 1 Results of sputum analysis for AFB in group I.
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Pulmonary tuberculosis (TB) is one of the leading causes of
mortality worldwide and has become a global public health
emergency [1]. Determination of pulmonary TB activity is as
important as early diagnosis of pulmonary TB in optimal
treatment strategy. Although novel diagnostic tools for sero-
logic tests, including QuantiFERON-TB Gold In-Tube and
T-spot. TB have been developed for rapid and accurate diag-
nosis of Mycobacterium tuberculosis infection, the results of
these tests have not been correlated with disease activity or ther-
apeutic responses [2,3]. Cancer antigen 125 (CA-125) is a high
molecular weight glycoprotein that is expressed on the epithelial
cells of the fallopian tube, endometrium, and mesothelial cells
lining the pleura, pericardium, and peritoneum [4]. CA-125 levels
are elevated in a number of malignant diseases such as those
involving the ovaries, lungs, breasts, colon, pancreas, and in
some non-malignant conditions including endometriosis, hepatic
cirrhosis or heart failure. Previously, it was reported that serum
CA-125 levels were higher in patients with pulmonary and extra-
pulmonary TB than healthy subjects. However, there have been
few reports on the relationship between the activity of pul-
monary TB and CA-125 levels [5].
Subjects and methods
This cohort prospective study included 80 subjects 60 patients
and 20 apparently healthy control subjects, the patients were
selected from Damitta Chest Hospital and Chest Department,
Benha University Hospitals in the period from July 2013 to
July 2014. The subjects were classiﬁed into 3 groups: group
I: included 40 patients with new diagnosed active pulmonary
tuberculosis, 35 males and 5 females, their ages ranged from
19 to 75 years. Group II: included 20 patients with pneumonia,
17 males and 3 females, their ages ranged from 22 to 80 years.
Group III: included 20 apparently healthy subjects as control
group, this group included 16 males and 4 females, their ages
ranged from 30 to 65 years.
Inclusion criteria for group I [6]
Sputum Smear Positive Pulmonary TB
Patients with at least two sputum specimen positive for Acid
Fast Bacilli by microscopy, patients with at least one sputum
specimen positive for Acid Fast Bacilli by microscopy, and
radiographic abnormalities consistent with pulmonary TB
and a decision by physician to treat with a full course of anti
TB chemotherapy were considered.
Sputum Smear Negative Pulmonary TB
Two sets (taken at least 2 weeks apart) of at least two sputum
specimens negative for Acid Fast Bacilli and radiographic
abnormalities consistent with pulmonary TB, lack of clinical
response despite 1 week of a broad spectrum antibiotic admin-
istration and a decision by physician to treat with a full cura-
tive course of anti-TB chemotherapy were considered.
Inclusion criteria for group II
Pneumonia diagnosed by clinical signs and symptoms
included: cough with or without sputum, fever >38.5,dyspnea, pleuritic chest pain or abnormal breath sounds, and
radiographic pulmonary abnormalities that are at least seg-
mental and are not due to preexisting or other known causes
[7].
Exclusion criteria
Patients with progressive malignancy, female patients with
non-malignant gynecologic conditions, such as endometriosis
and pregnancy diagnosed by clinical history, patients with hep-
atic cirrhosis or heart failure were excluded.
All subjects were subjected to:
(1) Full history taking: with special attention to fever, chest
pain, cough, loss of weight and appetite, night sweats, weak-
ness and malaise. (2) Full clinical examination: with special
attention to weight loss, and the presence of crepitations, or
bronchial breathing on chest examination. (3) Plain chest X-
ray PA view. Chest X-ray was done for diagnosis in group II
and to evaluate the disease severity in group I. Patients of
group I were classiﬁed according to their chest X-ray ﬁndings
as minimal, moderate advanced, far advanced [8]. (4) Sputum
examination for AFB for three successive days by direct smear
for group I & II [9]. (5) Tuberculin skin test [10]. (6) CBC and
ESR. (7) Liver and kidney functions. (8) Measurement of
serum level of CA-125 by ELIZA [11]. (9) Pelviabdominal
ultrasound and Echocardiography.
Statistical analysis
Statistical analyses were performed using SPSS version 19.0




Pulmonary TB, the most important type of TB from the public
health point of view, can be diagnosed by its symptoms, chest
radiography, sputum smear microscopy, and cultivation of
M. tuberculosis [12]. However, in some cases of pulmonary
TB, Acid Fast Bacilli stains in sputum samples may be nega-
tive or respiratory specimens may not be available, and other
methods have to be used to establish the diagnosis of TB
[13]. The tumor marker Cancer antigen 125 has been proposed
as a useful diagnostic tool for tuberculosis [14]. High levels of
Table 2 Classiﬁcation of group I according to X-ray ﬁnding.
Group I No %
X-ray
Minimal lesion 23 57.5
Moderate advanced 4 10.0
Far advanced 13 32.5
Total 40 100
Table 4 Comparison of CA 125 in the three groups according
to sex.
Male group Female group St t test P value
Mean SD Mean SD
Group I 68.35 72.74 46.2 44.22 Z= 0.757 0.449
Group II 17.75 9.47 21.83 3.36 0.725 0.478
Group III 7.19 3.35 6.7 – 0.139 0.893
CA-125 in diagnosis and assessment of pulmonary tuberculosis severity 207Ca-125 have been reported in patients with pulmonary and
extra-pulmonary tuberculosis, including pleural, peritoneal,
pelvic, miliary, and intraabdominal disease [15]. In the current
study 28 cases (70%) of group I were sputum +ve while 12
cases (30%) were sputum ve for AFB (Table 1). Kim et al.
[16] studied the clinical signiﬁcance of CA-125 in pulmonary
tuberculosis, his study included 100 patients with active pul-
monary tuberculosis that were divided into 47 (47%) patients
with +ve sputum and 53 (53%) patients with ve sputum
[16]. In the current study patients with minimal changes were
the most frequent (23 cases (57%)) (Table 2). These results
were not in agreement with those of Azza et al. [17] who stud-
ied the role of cancer antigen 125 in active pulmonary tubercu-
losis and found that among 27 cases of active pulmonary
tuberculosis 20 cases (74%) had moderate advanced disease
and 7 cases (26%) had far advanced disease with no patients
with minimal lesion [17]. In the current study there were statis-
tically signiﬁcant difference among the three studied groups
according to age, ESR & TST & serum level of CA 125
(P< 0.05). As age was signiﬁcantly higher in group II, ESR
was signiﬁcantly higher in group I, the size of tuberculin reac-
tion was signiﬁcantly higher in group I, the serum level of CA
125 was signiﬁcantly higher in group I (Table 3). These results
were in agreement with those of, Yilmaz et al. [5] who studied
the value of CA 125 in the evaluation of tuberculosis activity
and found that serum CA-125 levels were higher in patients
with pulmonary and extra-pulmonary TB than in healthy sub-
jects [5]. These results were also in agreement with those of
Azza et al. [17] who found that mean CA 125 levels were sig-
niﬁcantly higher among patients with active pulmonary tuber-
culosis (93.5 ± 138.9 U/ml) compared to healthy controls
(10.5 ± 7.3, P= 0.004) and pneumonia groups (31.2 ± 34.2,
P= 0.03) [17]. Kim et al. [18] studied serum CA-125 levels
in patients with non-tuberculous lung diseases and compared
it with patients with pulmonary tuberculosis, they found that
the mean value of CA 125 was signiﬁcantly higher among
patients with active pulmonary TB (54.5 ± 22.4) [18]. The
results of the current study were not in accordance with thoseTable 3 Comparison between the 3 groups according to age, ESR,
Variable Group I Group II
Age (in year) Mean ± SD 34.2 ± 15.15 46.15 ± 18.35
Range 19–75 22–80
ESR (mm/h) Mean ± SD 51.13 ± 19.99 13.8 ± 3.93
Range 22–100 6–20
TST (mm) Mean ± SD 13.5 ± 5.52 10.75 ± 2.53
Range 4–24 6–15
CA 125 (U/ml) Mean ± SD 65.58 ± 69.77 18.36 ± 8.89
Range 4.5–285.5 5.3–27.6of Ozsahin et al. [19] who studied the validity of the CA-125
level in the differential diagnosis of pulmonary tuberculosis,
and found that the mean CA-125 values of pneumonia, were
not statistically different from the mean value of patients with
pulmonary tuberculosis (P> 0.05) [19]. This difference may
be due to the difference in the severity of the comparable
groups in the different studies as regards the causative organ-
ism and the degree of inﬂammation, it may be also explained
by pleural involvement in patients with pneumonia. In the pre-
sent study, there was no signiﬁcant difference in serum level of
CA 125 regarding sex among all of the studied patients and
healthy controls (Table 4). This result was in agreement with
that of Fortu´n et al. [14], who studied CA-125 as a useful mar-
ker to distinguish pulmonary tuberculosis from other pul-
monary infections, and found that there was no signiﬁcant
difference between males and females as regards serum level
of CA 125 [14]. In the present study, serum CA 125 levels in
group I was signiﬁcantly higher in far advanced and moderate
advanced disease than minimal lesion one (Table 5). These
results were in agreement with those reported by Kanagarajan
et al. [20] who studied CA-125 as a reliable serum marker for
diagnosis of tuberculosis, and found that levels of CA-125
were the highest in cavitary pulmonary TB and in miliary
TB, so they concluded that we can take CA 125 as one of
the parameters in the assessment of severity of TB [20]. Also
these results were in agreement with those reported by Kim
et al. [18] who found that CA-125 levels appeared to be the
highest in patients with cavitary rather than nodular type
and this may reﬂect the level or extent of the infection [18].
In this study, there was a statistically signiﬁcant difference in
serum CA 125 levels in group I regarding the results of sputum
analysis for AFB (Table 6). Kim et al. [16] found that CA-125
was higher in patients with positive sputum for AFB than
those with sputum ve pulmonary tuberculosis [16]. In the
present study, there was a statistically signiﬁcant difference
between sputum negative pulmonary tuberculosis in group I
and group II regarding CA 125 (Table 7). In the current study,TST and serum level of CA 125.
Group III F test P value I&II I&III II&III
40.2 ± 7.54 4.1 0.021 S 0.01 0.233 0.337
30–52
9.2 ± 2.2 54.77 0.001 HS 0.001 0.001 0.002
6–13
5.5 ± 0.53 13.55 0.001 HS 0.039 0.001 0.001
5–6
7.14 ± 3.16 7.94 0.001 HS 0.004 0.012 0.001
3.6–11.9
Table 5 Comparison of serum level of CA 125 in group I according to X ray results.






F test P value
Group I 23.67 ± 10.33 37.0 ± 0.0 37.9 ± 24.22 19.68 0.001 HS
Table 6 Comparison of serum level of CA125 in group I according to the results of sputum analysis for AFB.
ve + ++ +++ F test P value
CA 125 37.9 ± 24.22 23.67 ± 10.33 37.0 ± 0.0 148.0 ± 76.3 19.68 0.001 HS





Mann whitney test P value
CA 125 37.9 ± 24.22 18.36 ± 8.89 2.02 0.005 HS
Table 8 Value of serum level of CA125 in diagnosis of
patients with active pulmonary tuberculosis.
CA 125 Group I Group II,
III
Total FET P value
No % No % No %
Positive 33 82.5 11 27.5 44 55 30.94 0.001
Negative 7 17.5 29 72.5 36 45








Figure 1 Roc curve of CA 125 in diagnosis of patients with
active pulmonary tuberculosis.
208 O.I. Mohammad et al.at a CA 125 serum level of 21.05 U/ml as a cut-off value, CA
125 had sensitivity, speciﬁcity, positive and negative predictive
values and diagnostic accuracy of 82.5%, 72.5%, 77.3%,
83.3% and 80.0% respectively. (Table 8 and Fig. 1). Azza
et al. [17] found that at a serum level of CA 125 of 34.6 U/
ml as a cut-off value, CA 125 had sensitivity, speciﬁcity, posi-
tive and negative predictive values and diagnostic accuracy of
81.4%, 95%, 95.6%, 79.2% and 87.2%, respectively [17]. For-
tu´n et al. [14] used a cut-off value of 32.5 IU/ml of CA-125 for
TB diagnosis, with sensitivity, speciﬁcity, positive predictive
value and negative predictive value of 68.6%, 77.8%, 66.7%
and 79%, respectively [14]. Yilmaz et al. [5] found a sensitivity
and speciﬁcity of CA 125 to be 97.5% and 100%, respectively
at a 31 U/ml cut-off point [5]. The lower cut off value in the
present study may be explained by the fact that most patients
(57%) had minimal lesion, 30% were sputum negative for
AFB, on the other hand in Azza et al. [17] there were no
patients with minimal lesion and no patients with sputum neg-
ative pulmonary tuberculosis [17]. All patients in Yilmaz et al.
[5] and Fortu´n et al. [14] were sputum positive for AFB. Also,the method used for determination of the level of CA 125 was
different from other studies, as ELISA was used in the current
study but in Azza et al. [17] Enzyme Linked Fluorescent Assay
(ELFA) was used [17]. Yilmaz et al. [5] used Packard Gamma
Counter RIA instrument and IRMA mat CA 125 II kit [5] and
in Fortu´n et al. [14] CA-125 was determined by an electro-
chemiluminescence test (Elecsys 1010, Roche), including a
radioimmunoassay (RIA) Packard Gamma counter [14].
Conclusion
Serum CA-125 may be used as a marker for diagnosis of
active pulmonary tuberculosis especially when tuberculosis is
CA-125 in diagnosis and assessment of pulmonary tuberculosis severity 209suspected clinically and radiologically in patients without spu-
tum production or sputum negative for AFB. Serum CA-125
may be used as a marker in assessment of severity of active pul-
monary tuberculosis.Conflict of interest
There is no conﬂict of interest.
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